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Abstract: Background: Fragmentation and delayed potentials in the QRS signal of patients have
been postulated as risk markers for Sudden Cardiac Death (SCD). The analysis of the high-frequency
spectral content may be useful for quantification. Methods: Forty-two consecutive patients with prior
history of SCD or malignant arrhythmias (patients) where compared with 120 healthy individuals
(controls). The QRS complexes were extracted with a modified Pan-Tompkins algorithm and
processed with the Continuous Wavelet Transform to analyze the high-frequency content (85–130 Hz).
Results: Overall, the power of the high-frequency content was higher in patients compared with
controls (170.9 vs. 47.3 103nV2Hz−1; p = 0.007), with a prolonged time to reach the maximal power
(68.9 vs. 64.8 ms; p = 0.002). An analysis of the signal intensity (instantaneous average of cumulative
power), revealed a distinct function between patients and controls. The total intensity was higher in
patients compared with controls (137.1 vs. 39 103nV2Hz−1s−1; p = 0.001) and the time to reach the
maximal intensity was also prolonged (88.7 vs. 82.1 ms; p < 0.001). Discussion: The high-frequency
content of the QRS complexes was distinct between patients at risk of SCD and healthy controls.
The wavelet transform is an efficient tool for spectral analysis of the QRS complexes that may
contribute to stratification of risk.
Keywords: electrocardiographic analysis; wavelet transform; high-frequency content; sudden
cardiac death
1. Introduction
1.1. Physiological Basis
Cardiac malignant arrhythmias (MA) are the major cause of sudden cardiac death (SCD) in
the general population, leading to great concerns in patients, physicians and health care systems
everywhere [1]. Despite extensive research on arrhythmia mechanisms and treatment, which leads to
highly effective therapies like implantable defibrillators, risk stratification continues to be a matter
under debate. Thousands of patients are implanted a defibrillator every year worldwide, jet a minority
of them will develop MA and benefits from the therapy. In addition, a significant part of them will
develop adverse reactions like infections or lead fractures. In an attempt to maximize the benefit
from the therapy and minimize adverse reactions, physicians would benefit from knowing a reliable
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source of data from the patients that allows for predicting future occurrence of MA, thus applying
preventive measurements (i.e., implantable defibrillators) with the maximum of the sensitivity and
specificity. Among a variety of technological tools for quantifying the risk, the stratification methods
based on the surface electrocardiogram (ECG) have always been preferred by clinicians due to its
widespread use, ease of access, simplicity in application and low associated cost. Under this perspective,
the spectral analysis of the ECG emerges as potentially useful, with the opportunity to contribute to
the risk stratification.
On the time domain analysis of the surface ECG, the fragmentation of the QRS complexes
is defined as notches that disrupt the linear progression of the time-voltage series recorded from
the body surface of the patients with an ECG sensor. Importantly, QRS fragmentation is gaining
increasing attention as a risk marker for the development of SCD or Malignant Arrhythmias (MAs)
that might help to stratification of risk in the clinical scenario [2,3]. In previous studies, the physiological
basis of fragmentation has been related to delays in conduction of the electrical wavefronts through
the myocardium, mostly secondary to the interposition of scar and fibrotic tissue [4,5]. The latter
mechanism also explain the late potentials usually recorded from the myocardium of patients with
ischemic cardiomyopathy [6,7] and other clinical entities with a high risk of SCD such as Hypertrophic
Cardiomyopathy [8] or Dilated Cardiomyopathy [9]. The Brugada Syndrome (BrS) [10,11] is a particular
case in which functional mechanisms promoting delayed conduction explain the occurrence of
delay/late potentials in the absence of fibrotic tissue [12]. Both fragmentation of the QRS and delayed
potentials have also been postulated as risk markers for SCD and MA in BrS patients [3,13].
Some studies have demonstrated a robust link between QRS fragmentation and late potentials [14].
Overall, fragmentation would represent a more prominent phenomenon that will allow for their
identification by visual inspection of the time domain record of the QRS complex, while less prominent
forms will be masked within the total energy/voltage of the normal myocardium, thus requiring signal
processing for appropriate identification. The signal average is a classical method applied to time
domain records [15,16]. Briefly, in this method a signal average is computed to increase the signal to
noise ratio. Thereafter, a high pass filter allows the detection of low voltage/high-frequency potentials
contained at the ending of the QRS complexes. However, the signal averaged ECG is highly dependent
on noise, requires long time records, and displays low sensitivity for the detection of high-frequency
content within the QRS (not at the end). In contrast, a variety of spectral methods may provide
efficient analysis of the QRS signal, enabling identification of late potentials by their subrogates in the
frequency domain: the high-frequency content [17]. As will be stated below, the Wavelet continuous
transform might also have the advantage to efficiently locate the high-frequency content along the
QRS complexes. The latter will be particularly interesting in characterizing dynamic process in which
the electrical conduction delay in the myocardium varies according to physiological or interventional
procedures [18].
1.2. The Wavelet Continuous Transform
As described by Roesch, the use of the Wavelet transform is a reasonable option to study periodic
phenomena in time series, particularly in the presence of frequency changes over time [19]. The medical
application of this technique for signal processing has been widespread since the early 1980s.
The Morlet wavelet was first described in the early 1980s [20–22]. It is based on the Gabor transform [23],
a Gaussian window sinusoid that allows decomposition of a signal in its frequency and phase content
over time [19]. Unlike the Gabor transform, the Morlet wave maintains its shape through frequency
changes, providing a separation of the contributions of different frequency bands without loss in
temporal resolution [22]. In summary, the Morlet wavelet is defined by the following equation, where w
represents the angular velocity or rotation, in radians per unit time:
ψ(t) = pi−1/4eivte
−t2
2 , (1)
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The Wavelet transform using the Morlet wavelet of a time series (xt) is defined as the convolution
of the series with a set of daughter wavelets generated by the mother wavelet by time translation and
scaled by s:
Wave(τ, s) =∑
t
xt
1√
s
ψ×
(
t− τ
s
)
, (2)
The position of the daughter wavelet in the time domain is determined by the displacement of
the time parameter in increments of dt. The local amplitude of any periodic component of the time
series and how it evolves over time can be obtained from the module of its wavelet transform [19].
The square of the amplitude constitutes the density of the wavelet energy in the time-frequency domain
and is called the energy spectrum of the wave [24]:
Power(τ, s) =
1
s
×
∣∣∣Wave(τ, s)2∣∣∣, (3)
1.3. The Use of the Wavelet Transform for the Study of the Surface Electrocardiogram
The Wavelet transform applied to the surface ECG has been analyzed in variety of clinical
scenarios. In the works by Gramatikov et al., the continuous Wavelet transform was used to detect
high-frequency content along the QRS in patients with acute ischemia, either provoked during a
coronary angioplasty procedure (mechanical occlusion of the artery lumen), or spontaneously occurring
in patients with acute ischemic heart disease (angina pectoris) [25,26]. An increase in the high-frequency
content during angioplasty (frequency range: 16–200 Hz) and during the acute ischemic episodes
(frequency range: 20–100 Hz) was observed in these studies, and subsequently normalized once
the ischemia disappeared. Similarly, Magrans et al., studied patients during a coronary angioplasty
procedure [27]. They found that, at the time of the angioplasty, the high-frequency content increased.
Remarkably, those changes were more pronounced at the terminal part of the QRS signal, thus
suggesting displacements of the high-frequency content along the QRS that must be consider in terms
of the signal processing and the interpretation of data. Another interesting field for study, in which
the wavelet transform of the QRS complexes has been successfully used, is to analyze patients with
specific electrical conduction delays requiring resynchronization therapy. With this regard, it has
been postulated that the use of the Wavelet transform might help to discern patients that will be
unresponsive to the therapy, thus avoiding costs and potential adverse events [28,29].
However, the number of patients included for analysis in those studies is low and the possibility
of implementing automatic systems for the analysis of QRS complexes has not been entirely evaluated.
The utility of the Wavelet transform to analyze the high-frequency content and to predict the risk of
MA or SCD have been poorly studied. Only the work of Murata et al., has shown an increase in the
high-frequency content of patients with MA or SCD compared to those without [17,30,31].
1.4. Pan-Tompkins Algorithm for Automatic Detection of QRS Complexes
The detection of QRS complexes is the first step for any automatic ECG analysis. There are many
methods for this purpose, with generally good performance, although each method has situations
where it fails. The algorithm published in 1985 by J. Pan and W. Tompkins is one of the most used
and allows the correct detection of the dominant peaks (R wave) of the QRS complexes [32]. In later
works the effectiveness of this algorithm has been evaluated and compared with other algorithms [33],
just confirming an adequate performance [34,35]. Briefly, the Pan-Tompkins algorithm is based on
4 sequential steps: (i) differentiation, (ii) squared elevation, (iii) integration with a moving window
and finally, (iv) selection of the detection threshold to select the R waves of the QRS complexes.
1.5. Hypothesis and Objectives
Hypothesis: The high frequency content of the surface ECG display distinctive characteristics in
patients under a risk of MA and SCD.
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Objective 1: To evaluate the ability of the Wavelet transform for the analysis, quantification and
temporal localization of high frequency content in QRS complexes, both in healthy controls and in
patients with a history of SCD or MA.
Objective 2: To analyze the contributing power and time distribution of the high frequency
content within the QRS complexes in patients and healthy controls in order to study differential
patterns between them.
2. Materials and Methods
2.1. Study Population
The group of patients was obtained from a consecutive registry of 42 patients with prior history of
Sudden Cardiac Arrest (SCA) or MA (patients), who came to our cardiac electrophysiology laboratory
for diagnostic or therapeutic purposes. The term SCA was used to describe sudden death cases in which
specific resuscitation records were available or the individual had survived the cardiac arrest event [35].
SCD was defined as an unexpected death without obvious extracardiac cause, occurring with a rapid
witnessed collapse, or if un-witnessed, occurring within 1 h after the onset of symptoms. SCD was
considered probable if occurred unexpectedly without obvious extracardiac cause within the previous
24 h. In any situation, the death should not occur in the setting of a prior terminal condition, such as a
malignancy that was not in remission or end-stage chronic obstructive lung disease [35]. MA were
defined as sustained life-threatening ventricular arrhythmia (Ventricular Tachycardia or Ventricular
Fibrillation), which finished spontaneously or with treatment (pharmacological or electrical). A control
group of 120 healthy individuals (controls) were analyzed. In all of them cardiac examination was
performed to rule out any cardiac disease.
For the collection of electrocardiographic data the ethical committee approval was first obtained
(Asturias regional ethical committee for clinical research, project number 35/2013). In addition,
the investigations were carried out following the rules of the Declaration of Helsinki of 1975, revised
in 2008.
2.2. Collection of Electrocardiographic Data: The ECG Sensor
The standard ECG (12 leads) of the patients included in the study were digitally collected with the
commercially available ECG sensor EPTracer® from CardioTek© Electrophysiological Measurement
System, Maastricht (here in after the EPTracer sensor). The EPTracer sensor is a computerized
system designed for both clinical and experimental electrophysiological studies, allowing real-time
visualization of the ECG signal and continuous storage (12 bit resolution, up to 1 kHz sampling rate,
and a maximal differential input-voltage of +/−5 mV recording). As displayed in Figure 1, panels
A & B, the potential at different sites of the body surface was explored by 10 exploring electrodes
distributed according to clinical standards. The opposite extremes of the electrodes were connected
to a multi-channel amplifier (panel C), where potential differences (ECG signals or leads) were
computed between pairs of electrodes or calculated against an indifferent electrode (central terminal of
Wilson) [36,37]. ECG signals underwent filtering at the EPTracer sensor (linear-phase digital band-pass
filter: 0.05–150 Hz to suppress low-frequency noise that results from baseline wander, movement, and
respiration, and higher-frequency noise that results from muscle artifact, and power-line or radiated
electromagnetic interference) [37] and amplification. A notch filter was also applied at the 50 Hz
frequency, in order to eliminate the power-line interference.
Sensors 2018, 18, 560 5 of 15
Sensors 2018, 18, x FOR PEER REVIEW  5 of 15 
 
 
Figure 1. Electrocardiogram (ECG) recording and characteristics of the EPTracer sensor.  
(A) Schematic diagram representing the standard position of the exploring electrodes (green dots) on 
the body surface. (B) According to the position of the exploring electrodes on the body surface, and 
the configuration of pairs for computing differences in potential, the ECG signals receive 
standardized names. L, R, F, V1, V2, V3, V4, V5, and V6 constitute the differences in potential 
between the corresponding electrode and an indifferent electrode (central terminal of Wilson). In 
addition, three ECG signals are computed as the algebraic sum of potentials at different pairs of 
electrodes (lead I = L + R; lead II = R + F; Lead III = L + F). (C) EPTracer sensor front panel. 
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For the purpose of the study, the ECG records were performed continuously for at least 12 
consecutive seconds (Figure 2A). To extract the QRS complexes, we propose a modified algorithm of 
the originally described by Pan-Tompkins [32]. As previously described, the latter consisted of four 
consecutive steps: differentiation, squared elevation, detection threshold calculation, and correction 
by local maxima. However, in order to make spectral comparisons between subjects that affected the 
amplitude and the timing of the high frequency content, there is a need for: (i) normalizing the 
amplitude of the QRS signal; and (ii) select a stable reference for timing. After normalization, we 
would need also to select appropriate new thresholds for QRS detection. The latter is the rationale 
for the modifications that we introduced in the originally described Pan-Tompkins algorithm, 
summarized as follows (see also Figure 2): 
First, we normalized the ECG signal to allow appropriate comparisons between leads  
and patients. 
In order to determine the threshold for detection of the R-wave in the QRS complexes 
(after differentiation and squared elevation of the signal), the 99.5 percentile of the signal 
(P99.5) was calculated. All the extreme values (defined as those greater than P99.5) were 
removed and the signal was typified over the value of P99.5 (Figure 2B). A threshold of 0.6 
defined the time points where there were QRS complexes (tQRS; red line in Figure 2B). 
A temporal correction was performed for the morphology of the QRS complexes. To do 
this, the point of the QRS complex with a higher positive voltage value in the V6 derivation 
was selected (tMaxQRS; red line in Figure 2C), because clinically it is the lead in which the 
peak of the R wave is better defined. 
Finally, to subtract the QRS complexes for analysis a window of 145 ms around the tMaxQRS 
point was selected (from 60 ms before tMaxQRS to 85 ms after tMaxQRS; Figure 2C). 
Figure 1. Electrocardiogram (ECG) recording and characteristics of the EPTracer sensor. (A) Schematic
diagram representing the standard position of the exploring electrodes (green dots) on the body surface.
(B) According to the position of the exploring electrodes on the body surface, and the configuration of
pairs for computing differences in potential, the ECG signals receive standardized names. L, R, F, V1,
V2, V3, V4, V5, and V6 constitute the differences in potential between the corresponding electrode and
an indifferent electrode (central terminal of Wilson). In addition, three ECG signals are computed as the
algebraic sum of potentials at different pairs of electrodes (lead I = L + R; lead II = R + F; Lead III = L + F).
(C) EPTracer sensor front panel.
2.3. Extraction of QRS Complexes Using a Modified Pan-Tompkins Algorithm
For the purpose of the study, the ECG records were performed continuously for at least
12 consecutive seconds (Figure 2A). To extract the QRS complexes, we propose a modified algorithm
of the originally described by Pan-Tompkins [32]. As previously described, the latter consisted of four
consecutive steps: differentiation, squared elevation, detection threshold calculation, and correction
by local maxima. However, in order to make spectral comparisons between subjects that affected
the amplitude and the timing of the high frequency content, there is a need for: (i) normalizing the
amplitude of the QRS signal; and ( i) select a stable refere ce for tim ng. After normalization, we would
need also to select appropriate new thresholds for QRS detection. The latter is the rationale for the
modifications that we introduced in the originally described Pan-Tompkins algorithm, summarized as
follows (see also Figure 2):
First, we normalized the ECG signal to allow appropriate comparisons between leads
and patients.
In order to determine the threshold for de ection of the R-wave in the QRS complexes (after
differe tia ion and squared el vation of the signal), the 99.5 pe centile of the signal (P99.5)
was calculated. All the extreme values (defined as those greater than P99.5) were removed
and the signal was typified over the value of P99.5 (Figure 2B). A threshold of 0.6 defined
the time points where there were QRS complexes (tQRS; red line in Figure 2B).
A temporal correction was performed for the morphology of the QRS complexes. To do
this, the point of he QRS co plex with higher positive voltage value in the V6 derivation
was selected (tMaxQRS; red line in Figure 2C), because clinically it is the lead in which the
peak of the R wave is better defined.
Finally, to subtract the QRS complexes for analysis a window of 145 ms around the tMaxQRS
point was selected (from 60 ms before tMaxQRS to 85 ms after tMaxQRS; Figure 2C).
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Figure 2. Example of the ECG processing and the QRS extraction. rface ECG (12 consecutive
seconds). The blue arrow indicates a QRS complex. (B) Signal after eri ation, square elevatio and
typification. The 0.6 threshold to detect the QRS complexes is denoted (red line). The blue arrow
indicates a QRS complex after processing. (C) Example of an extracted QRS complex. The tMaxQRS is
indicated by the red line. ECG: electrocardiogram.
In order to evalu te the algorithm, we c mpared our modified algori ’s performance against
other published algorithms. For this purpose we used the MIT-BIH Arrhy hmias Database [38],
and calculated the Sensitivity (Se), Positive Predictive Value (PPV), Error (Er), Total Beats (TB),
False Positives (FP) and False Negatives (FN), as described in previous methods [32,39–42].
2.4. Wavelet Continuous Transformation for the Analysis of the High-Frequency Content
The time-frequency data of each QRS complex were collected using the Wavelet transform (Morlet
wavelet). According to previous definitions of high frequency content in other works [14–17], data were
analyzed in the defined range of high frequencies (85–130 Hz), with an upper period of 11.5 ms and
lower period of 7.7 ms (Figure 3A). A temporal definition of 1 kHz and a frequency resolution of 1/125
suboctaves were used. Calculations for the Wavelet Continuous Transform were performed with the
WaveletComp library [19] for R [43].
2.5. Quantification of High-Frequency Content in the QRS Complexes
To analyze the distribution of the high-frequency content along the QRS signal, we computed the
cumulative power contained at each time epoch of the QRS complex (Figure 3B). From the obtained
distribution we defined (i) the Peak Power as the highest cumulative power of the high-frequency
content (red dotted line in Figure 3B); (ii) the Time to Peak Power as the time epoch where Peak Power
was reached (green dotted line in Figure 3B); and (iii) the Total Power as the area under the curve of the
whole power function.
In addition, we calculated the relativ co tribution of the high-frequ ncy content to the total power
of the QRS complexes as a function of time: (i) at the i itial part of the QRS complex (prior to tMaxQRS)
named the Initial High Frequency Contribution; and (ii) at the final part of the QRS (after tMaxQRS)
named the Final High Frequency Contribution. The ratio between the initial and final contribution was
defined as the High Frequ ncy C tribution Rat o.
2.6. Intensity Analysis
For a better description of the distribution of the high-frequency content along the QRS complex,
the spectral intensity of the high-frequency content throughout the entire QRS complex is calculated.
Intensity was defined as the instantaneous average of cumulative power and computed according to
the following equation:
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Intensity(t) =
1
dt
×
t
∑
i=1
(Poweri), (4)
where Poweri is the average high-frequency power in t = i and dt is the time elapsed until each time
epoch. On the spectral intensity function we defined: (i) the Peak Intensity as the highest intensity in
the intensity function (red dotted line in Figure 3C); (ii) the Time to Peak Intensity as the time epoch
where Peak Intensity was reached (green dotted line in Figure 3C), (iii) the Final Intensity as the intensity
value at the ending point of the intensity function (blue dotted line in Figure 3C); and (iv) the Total
Intensity as the area under the curve of the whole function.
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2.7. tatistical alysis
I itiall , a descriptive statistical analysis of the baseline variables of the patients was performed to
characterize the study population. Categorical variables are expressed as percentage and the continuous
quantitative as Mean ± Standard Error. For the contrast between patients a d controls, a Chi square
test was performed for the categorical variables and the Student’s T test for the continuous variables,
in all cases with a significance level of 0.05. The qua tification of the parameters used t analyze
the high-frequency content along t e entire QRS complex, as well as the spectrogram intensity in
the high-frequency range is expressed as Mean ± Standard Deviation. For the contrast between the
patients and the controls we used a Student’s T test. Statistical calculations were performed with the
statistical software R [43].
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3. Results
3.1. Population Characteristics
We analyzed data from 162 individuals (120 healthy controls and 42 patients). Table 1 summarizes
clinical characteristics. No statistical differences between both groups were found. Ischemic Heart
Disease (28.57%) and BrS (26.19%) were the most frequently observed pathology in patients. All of
them had suffered at least an episode of MA, and 11.9% had experienced an episode of SCA.
Table 1. Population characteristics.
Variables Controls (n = 120) Patients (n = 42)
Age (years) 53.3 ± 14.37 59.6 ± 18.26
Male (N/%) 67 (55.8) 34 (80.95)
Cardiomyopathy (N/%) 0 (0) 42 (100)
Ischemic NA 12 (28.57)
Idiopathic NA 4 (9.52)
BrS * NA 11 (26.19)
Others NA 15 (35.71)
Arrhythmic Events (N/%) 0 (0) 42 (100)
SCA * NA 5 (11.9)
MA * NA 42 (100)
* BrS: Brugada Syndrome; SCA: Sudden Cardiac Death; MA: Malignant Arrhythmias.
3.2. Comparative Analysis between Different QRS Detection Algorithms
As previously stated, the proposed modifications in the Pan-Tompkins algorithm were designed
to allow appropriate comparisons of the high frequency content between different subjects. Although
improving detection features was out of our goal, we consider appropriate to display the performance
of the modified algorithm in comparison with others. Table 2 display that Sensitivity and Positive
Predictive Values of our modified algorithm remain in the range of those previously published for
other methods. However, the Sensitivity and the Positive Predictive Value are slightly lower for our
modified Pan-Tompkins in comparison with the originally described.
Table 2. Comparative analysis between different QRS detection algorithms.
Algorithm Database Se (%) PPV (%) Er TB FP FN
J. Pan et al. (1985) [32] MITDB 99.75 99.53 0.675 116137 507 277
J.P. Martinez et al. (2004) [42] MITDB 99.8 99.86 0.34 107567 153 220
Z. Zidelmal et al. (2012) [39] MITDB 99.64 99.82 0.54 109494 193 393
R. Tafresi et al. (2014) [40] PTBDB 99.06 98.9 N/A N/A N/A N/A
M. Yochum et al. (2016) [41] CinCC11 99.87 91.71 N/A N/A N/A N/A
Present Work MITDB 98.45 96.67 3.53 114654 2567 1125
* Se: Sensitivity; PPV: Positive Predictive Value; Er: Error; TB: Total Beats; FP: False Positives; FN: False Negatives.
3.3. Analysis of the High-Frequency Content
Overall, patients had significantly higher high-frequency content along the QRS complex than
controls (data summarized in Table 3 & Figure 4). The Total Power and the Peak Power were significantly
higher in patients compared with controls. The Time to Peak Power was also prolonged in patients
with regard to controls, thus demonstrating differences not only in the absolute values, but also in
the distribution of the high-frequency content along the QRS. However, when analyzing the relative
contribution of the high-frequency content there were no differences in the High Frequency Contribution
Ratio between patients and controls. That probably means a global displacement of the total frequency
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content to more distal positions in patients compared with controls. The latter is well exemplified in
a patient with BrS in which, at different states of the pathology, the time domain record of the QRS
complex displayed progressively delayed components (moving waves; Figure 5, black arrow) at the
terminal part of the QRS. This case illustrates that as the ECG record becomes more pathological,
the position of the moving wave is located at more delayed positions of the QRS. With regression to
normal ECG tracings, the moving wave returns to more proximal positions.
Table 3. Summary of high-frequency analysis.
Variables Controls (n = 120) Patients (n = 42) p
Peak Power (103nV2Hz−1) 1.709 (± 1.13) 7.033 (± 15.09) 0.028
Time to Peak Power (ms) 64.768 (± 5.868) 68.952 (± 7.609) 0.002
Total Power (103nV2Hz−1) 47.298 (± 26.129) 170.782 (± 282.714) 0.007
Initial High Frequency Contribution
(103nV2Hz−1) 2.012 (± 1.21) 5.409 (± 4.97) <0.001
Final High Frequency Contribution
(103nV2Hz−1) 45.287 (± 25.601) 165.463 (± 280.608) 0.008
High Frequency Contribution Ratio 0.053 (± 0.034) 0.069 (± 0.049) 0.059
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of prognosis significa ce in pati nts with different pathologies, which in conjunction with the analysis
of ot er clinical variables, lik cardiac syncop and structural abnormalities, might contribute to better
stratific tion of risk and more appropriate measurements to t ke in der to reduc th risk of SCD.
In ddition, the analysis proposed in our work is feasible for an automatized, o -line analysis of ECG
records that woul allow quick evaluation of patien s.
The l t ti o s transfor has been proposed as a seful technique for studying the
frequency po er spectru , and especia ly to study the te poral distribution of the high-frequency
conte t complexes. In this ense, it is importan to remark how this con titutive part along
the QRS may present a dy amic behavior with time and also change under different clinical situat ons
even within the same patient. At d fferent states of the pathology the m rphology of the ECG may
change, which might make diagnosis of those patients difficul [18]. In addi ion, those changes on the
ECG morphology may also change the distribution of the frequency content along the QRS, depending
on the severity of the disease or the administration of various drugs. For example, in Fig re 5 we
display the case of a patient di gnosed with BrS. The ECG recor s show how there is a displacement
of la e potential towards a later position within the QRS complex as t e ECG demonstrates more
pathological conditions (from Brugada type III to B ugada Type I). This dynamic behavior makes it
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important to consider analytical techniques that are able to track the displacements in the frequency
content in order to increase precision and sensitivity. We also previously demonstrate that ventricular
fibrillation, the most lethal arrhythmia causing SCD in patients, is characterized by a highly dynamical
behavior in the frequency content, but with maintenance of a hierarchical organization at the phase
spectrum [13]. The latter allows for spatial location of the sources that eventually maintain the
arrhythmia, and pave the way for automatized analytical methods able to efficiently track those
dynamical changes and displacements of the frequency content that would help for developing more
efficient clinical procedures.
Compared with other techniques focused on the time or frequency domain, we consider that
the wavelet transform may provide significant advantages. Although firstly reported, the analysis
of QRS fragmentation on the time domain may be less useful than the analysis of the high-frequency
content to detect patients at risk for SCD [2,8,9]. The main limitation of the analysis of fragmentation
is that it is based on a subjective classification, with no absolute measurements, and thus it is more
difficult to standardize. Also they are less sensitive than frequency domain analysis [44]. In addition,
unlike other techniques for the analysis of the frequency power spectrum (i.e., Fast Fourier Transform),
the time-frequency analysis (i.e., Wavelet transform) also allows for the location of high-frequency
content along time [45], which can help to identify significant displacements as discussed before.
There are other techniques for time-frequency analysis, mainly the signal-averaged electrocardiogram [45],
which is one of the first described techniques for high-frequency analysis in QRS complexes [15,16].
As stated at the introduction section, this technique may fail in situations with high noise to signal
ratio, it requires long ECG records, and it is only useful in the terminal part of the QRS, not in the
whole QRS complex [46]. Spectral methods provide a more efficient analysis of the QRS signal [17]
and we have found the Wavelet transform particularly useful in our patients.
5. Conclusions
The high-frequency content of the QRS complexes distinctively behaves between patients at high
risk of SCD, and healthy controls. The wavelet transform is an efficient tool for spectral analysis of
the QRS complexes that allows for quantifying the differential behavior between both studied groups.
Future research is needed to clarify how the proposed technique may contribute to stratification of
patient risk.
6. Limitations
Differences between patients with and without MA/SCA were not evaluated, thus we cannot
ascertain the predictive capabilities in patients in primary prevention. Patient groups had a higher
percentage of men than the control group. Because there may be some differences in QRS characteristics
associated with gender, it could explain, to some extent, the differences observed between groups.
Overall, to analyze the global utility of the Wavelet transform, comparisons with other techniques
are required. In order to develop an automatic method for quantification and characterization of
high-frequency content there is need for combining the relevant metrics (high frequency content timing
and magnitude) using a machine learning technique, and assessing its performance. Both will be
desirable but were not tested/performed in our work.
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